-
- Posts: 193
- Joined: Thu May 11, 2006 11:10 pm
I was assigned to develop an assay for a polymer (let's just called it NewX). The manufacturer provided no assay to demonstrate purity. The C of A has info on solid content (yy%), but not potency. Because I don't want to affect the marketing strategy of our company, I prefer to leave out the chemical name of 'NewX.'
I have had difficulties with the method development, because of the followings: lack of expertise, lack proper detector (we have UVD, RID, and ELSD, but no MS), no official monograph, no reference standard, and the low level of the NewX in the final product.
This NewX is not retained by a traditional C18 or C8 column. When I tried on a short macropore (5um, 300A) C18 column used for peptides, I got a nice peak but it was not reproducible! When a longer macropore C18 column is used with gradient elution, I got 3 clusters of peaks in ELSD (this NewX has weak UV abs). I realized that the portions of NewX eluted at approx. 25%, 60%, and 90% organic (I recall these # from my memory). I have reported this 'discovery' to my upper people, but they only want to know when a test is developed.
I also tried to check the MW distribution (actually, the dynamic volume) of diluted NewX, using one GPC 7.8x300mm column. From that run, it appeared that NewX had at least three groups of significant different MW ave (could be more than one order of magnitude).
My questions are:
1. How to quantify NewX if it contains at least three distinct groups of polymers (not just differ in chain length).
2. How to create an in-house standard, when we can't buy one.
3. Should we replace NewX by something else more uniform/homogeneous.
Thank you.